Author: Jill Ettinger

Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic Research

January 22, 2021June 2, 2024 Business, Learn, Treatment

Wesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue its psychedelic research for traumatic brain injuries.

January 15, 2021June 2, 2024 Business, Learn

This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.

January 14, 2021June 2, 2024 Culture, Travel, Treatment

With Oregon’s recent victory for psychedelics, psilocybin retreats could soon be commonplace. What does that mean for mental health treatment?

January 8, 2021June 2, 2024 Business, Learn

This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.

January 5, 2021June 2, 2024 Business, Learn

NeonMind is the latest psychedelic company to go public. It’s the first to launch on the Canadian Stock Exchange in 2021.

December 31, 2020June 2, 2024 Business, Learn

The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.

December 17, 2020June 2, 2024 Business, Learn

The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson’s, and more business news.

December 10, 2020June 2, 2024 Learn, Research

The UK will begin the first DMT trials for depression after Imperial College received approval to test the psychedelic.

December 10, 2020June 2, 2024 Business, Learn

This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.

December 9, 2020June 2, 2024 Business, Learn

Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.

End of content